DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories Limited
02 1Moehs Catalana SL
03 1AURORE PHARMACEUTICALS PRIVATE LIMITED
04 1AX Pharmaceutical Corp
05 1Arene Life Sciences Private Limited
06 1Aurobindo Pharma Limited
07 1Cadila Pharmaceuticals Limited
08 1Cipla Ltd.
09 1DARMERICA, LLC
10 1Fagron Inc
11 1Glochem Industries Private Limited
12 1Hetero Drugs Limited
13 1Ipca Laboratories Limited
14 1MYLAN LABORATORIES LIMITED
15 1Medisca Inc.
16 1Novartis Pharmaceuticals Corporation
17 1Pfizer Asia Manufacturing Pte Ltd
18 1Professional Compounding Centers of America dba PCCA
19 1Spectrum Laboratory Products, Inc.
20 1Srini Pharmaceuticals Private Limited
21 1Tianish Laboratories Private Limited
22 1Unichem Laboratories Limited, India
23 1Viatris Pharmaceuticals LLC
24 1Xenex Laboratories Inc
25 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
26 1Zydus Lifesciences Limited
01 8AMLODIPINE BESYLATE
02 15Amlodipine Besylate
03 1Amlodipine Besylate (Process 1)
04 1Amlodipine Besylate Anhydrous
05 1amlodipine besylate
01 2Canada
02 1China
03 13India
04 1Netherlands
05 1Spain
06 1Switzerland
07 6U.S.A
08 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-025
Start Marketing Date : 2003-03-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 52932-0723
Start Marketing Date : 2010-07-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7561
Start Marketing Date : 2016-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-1438
Start Marketing Date : 2012-04-01
End Marketing Date : 2027-02-27
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 24234-0009
Start Marketing Date : 2014-01-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2734
Start Marketing Date : 2014-05-23
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0078-1476
Start Marketing Date : 2007-06-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-0429
Start Marketing Date : 2015-06-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53747-011
Start Marketing Date : 2003-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0073
Start Marketing Date : 2020-04-21
End Marketing Date : 2027-10-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
92
PharmaCompass offers a list of Amlodipine Besylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amlodipine Besylate manufacturer or Amlodipine Besylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amlodipine Besylate manufacturer or Amlodipine Besylate supplier.
PharmaCompass also assists you with knowing the Amlodipine Besylate API Price utilized in the formulation of products. Amlodipine Besylate API Price is not always fixed or binding as the Amlodipine Besylate Price is obtained through a variety of data sources. The Amlodipine Besylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A S (-) AMLODIPINE BESILATE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of S (-) AMLODIPINE BESILATE, including repackagers and relabelers. The FDA regulates S (-) AMLODIPINE BESILATE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. S (-) AMLODIPINE BESILATE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of S (-) AMLODIPINE BESILATE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A S (-) AMLODIPINE BESILATE supplier is an individual or a company that provides S (-) AMLODIPINE BESILATE active pharmaceutical ingredient (API) or S (-) AMLODIPINE BESILATE finished formulations upon request. The S (-) AMLODIPINE BESILATE suppliers may include S (-) AMLODIPINE BESILATE API manufacturers, exporters, distributors and traders.
click here to find a list of S (-) AMLODIPINE BESILATE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing S (-) AMLODIPINE BESILATE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for S (-) AMLODIPINE BESILATE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture S (-) AMLODIPINE BESILATE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain S (-) AMLODIPINE BESILATE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a S (-) AMLODIPINE BESILATE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of S (-) AMLODIPINE BESILATE suppliers with NDC on PharmaCompass.
We have 24 companies offering S (-) AMLODIPINE BESILATE
Get in contact with the supplier of your choice:
